CENTERS OF EXCELLENCE
Solid Tumor Center & Surgery
Neuroblastoma, Wilms tumor, hepatoblastoma & sarcoma
A multidisciplinary solid tumor program where every child is reviewed jointly by surgery, oncology, radiology, pathology and nuclear medicine. Organ-sparing and limb-salvage surgery is combined with MIBG therapy, immunotherapy and precision diagnostics.
>92%
Wilms tumor 5-yr survival
>90%
Limb-salvage rate
Featured Programs
Signature Features
Neuroblastoma MDT
Surgery + chemotherapy + MIBG therapy + GD2 immunotherapy, sequenced by a weekly multidisciplinary board.
Limb-salvage & 3D printing
Custom 3D-printed extendable implants preserve limbs and growth for children with bone sarcoma — limb-salvage rate above 90%.
Organ-sparing surgery
Nephron-sparing and liver-sparing techniques preserve organ function whenever oncologically safe.
Conditions Treated
- Neuroblastoma (all risk groups)
- Wilms tumor (nephroblastoma)
- Hepatoblastoma & liver tumors
- Osteosarcoma & Ewing sarcoma
- Rhabdomyosarcoma & soft-tissue sarcoma
- Germ cell tumors
Expert Team
Prof. Dong Kuiran
Professor · Director, Oncology Surgery
Pediatric Solid Tumor Surgery · Shanghai
Prof. Tang Jingyan
Professor · Doctoral Supervisor, Hematology-Oncology
Pediatric Solid Tumors & Lymphoma (MDT) · Shanghai
Prof. Li Long
Professor · Chief of Pediatric Surgery
Minimally Invasive Pediatric Surgery · Beijing
Not sure which center fits your child?
Send us your child's medical records — our pediatric coordinators will match you with the right specialty center and return a written opinion within 48 hours.
Free Case Review